Likewise, amplification became the primary type of MEIS1 gene alteration in ovarian epithelial tumor, bladder urothelial carcinoma, mature B-cell neoplasms and prostate adenocarcinoma. The gene discussed is MEIS1; the disease is bladder transitional cell carcinoma.